Literature DB >> 7173718

Pyrimidine nucleoside phosphorylase activity in tumour and matched normal gastrointestinal mucosa.

B Higley, J Oakes, J De Mello, G R Giles.   

Abstract

5-Fluorouracil (5-FU) requires activation to the metabolites FdUMP and FUTP for its cytotoxic effect. This activation involves the intracellular enzymes uridine and thymidine phosphorylase. We have assayed the levels of these enzymes in colorectal and gastric cancers and have shown that, in the majority of cases, the enzyme levels were higher than in the adjacent normal mucosa. It is suggested that, while the ratio tumour/normal mucosa enzyme activity may give some indication of the relative toxicity of 5-FU in these tissues, the absolute activities of the phosphorylases in tumour tissue could give a better indication of tumour responsiveness.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173718      PMCID: PMC1419845          DOI: 10.1136/gut.23.12.1072

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Clinical management of advanced gastrointestinal cancer.

Authors:  C G Moertel
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. II. Correlation between the tumor levels of the enzyme and the 5-fluorouracil-promoted increase in survival of tumor-bearing mice.

Authors:  P Reyes; T C Hall
Journal:  Biochem Pharmacol       Date:  1969-10       Impact factor: 5.858

3.  Response and survival in advanced carcinoma without severe antitumor drug toxicity.

Authors:  E D Savlov; C D Sherman; T C Hall; W A Nahhas
Journal:  Dis Colon Rectum       Date:  1970 Nov-Dec       Impact factor: 4.585

4.  Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

Authors:  R J Langenbach; P V Danenberg; C Heidelberger
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

5.  Pyrimidine nucleoside phosphorylases of rat liver. Separation by ion exchange chromatography and studies of the effect of cytidine or uridine administration.

Authors:  E W Yamada
Journal:  J Biol Chem       Date:  1968-04-10       Impact factor: 5.157

6.  Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture.

Authors:  J D Laskin; R M Evans; H K Slocum; D Burke; M T Hakala
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

Review 7.  Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial.

Authors:  S K Carter
Journal:  J Natl Cancer Inst       Date:  1976-08       Impact factor: 13.506

8.  Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.

Authors:  S Spiegelman; R Nayak; R Sawyer; R Stolfi; D Martin
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

Review 9.  An overview of thymidine.

Authors:  D S Martin; R L Stolfi; R C Sawyer; R Nayak; S Spiegelman; C W Young; T Woodcock
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

10.  Metabolism of 5-fluorouracil in sensitive and resistant tumor cells.

Authors:  M Fukushima; K Ikenaka; T Shirasaka; S Fujii
Journal:  Gan       Date:  1979-02
View more
  1 in total

1.  Incorporation of intermediary products of 5-FU anabolism into colorectal cancer.

Authors:  G R Giles; L Woodhouse; P J Finan; E M Chisholm
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.